Summary
Elevance Health, Inc., then operating as WellPoint, Inc., filed this Form 8-K on March 17, 2010, to disclose its 2010 financial outlook during a conference call for securities analysts and investors. The company provided key financial and operational guidance, excluding the potential impact of federal health care reform and contingent on obtaining actuarially sound rate increases. The outlook offered insights into expected net income, membership growth, revenue, medical cost trends, and expense ratios, providing a forward-looking view of the company's performance expectations for the year. Of note, the disclosure highlighted an expected net income of at least $6.00 per share and a target of 33.3 million members by year-end. Operating revenue was projected to reach approximately $59.0 billion. The report also detailed expectations for the benefit expense ratio and underlying local group medical cost trend, alongside the SG&A expense ratio. Operating cash flow was forecast at $1.1 billion, though this figure was impacted by tax payments related to the sale of NextRx and the run-off of exited business lines.
Key Highlights
- 1WellPoint (now Elevance Health) provided its 2010 financial outlook on March 17, 2010.
- 2Expected net income for 2010 is at least $6.00 per share.
- 3Projected year-end medical enrollment of 33.3 million members.
- 4Anticipated operating revenue of approximately $59.0 billion for 2010.
- 5The benefit expense ratio is expected to be around 84.3%.
- 6Underlying local group medical cost trend projected between 7.5% and 8.5%.
- 7Operating cash flow guidance of approximately $1.1 billion, with specific notes on impacts from tax payments and business line run-offs.